TrialPanorama/TrialPanorama-database huggingface dataset:
Study 37131217 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 37131265 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 37131861 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37131861 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37133586 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37133584 — Predictive Biomarker (PRD): Hormone receptor
Study 37133585 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 37133647 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 37133829 — Surrogate Endpoint (SUR): Blood pressure
Study 37133926 — Surrogate Endpoint (SUR): Blood pressure
Study 37134108 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study 37134108 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 37134130 — Predictive Biomarker (PRD): STAT4 mRNA
Genes: STAT4
Study 37134130 — Predictive Biomarker (PRD): PRKCA mRNA
Genes: PRKCA; PKCA; PRKACA
Study 37134294 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 37137248 — Predictive Biomarker (PRD): PARN mRNA
Genes: PARN; DAN
Study 37137553 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 37137660 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37137660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37137660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37137660 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 37137672 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 37138473 — Surrogate Endpoint (SUR): Serum uric acid
Study 37138751 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 37138751 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 37139076 — Surrogate Endpoint (SUR): Blood pressure
Study 37139665 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37139665 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 37139665 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 37139665 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 37139665 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37139665 — Monitoring Biomarker (MOI): Cell-free DNA
Study 37140539 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 37140602 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37140602 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37140602 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 37140705 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37141237 — Surrogate Endpoint (SUR): Blood pressure
Study 37141294 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37141544 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 37141544 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37141764 — Predictive Biomarker (PRD): MGAT1 mRNA
Genes: MGAT1; GGNT1; GLCT1; GLYT1; MGAT
Study 37141764 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 37141828 — Predictive Biomarker (PRD): Microsatellite instability
Study 37141847 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37141847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 37142177 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 37142372 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37142474 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 37142730 — Predictive Biomarker (PRD): TPX2 mRNA
Genes: TPX2; C20orf1; C20orf2; DIL2; HCA519
Study 37142733 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 37142733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37143108 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 37143128 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 37143154 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study 37143408 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 37143685 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37143998 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 37144150 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 37144150 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 37144150 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 37144634 — Surrogate Endpoint (SUR): Bone mineral density
Study 37144820 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 37145169 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 37145169 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 37145169 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37145169 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 37145600 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 37145975 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37146752 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37147298 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 37147298 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37147301 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 37147496 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 37147645 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 37147645 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 37147930 — Surrogate Endpoint (SUR): Blood pressure
Study 37148249 — Pharmacodynamic Biomarker (PDY): C-type lectin domain family 4 member C
Genes: CLEC4C; BDCA2; CLECSF11; CLECSF7; DLEC; HECL; UNQ9361/PRO34150
Study 37148266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37148474 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 37148485 — Predictive Biomarker (PRD): FMO3 mRNA
Genes: FMO3
Study 37148485 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 37149818 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37149818 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 37149930 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 37150147 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 37151105 — Surrogate Endpoint (SUR): Bone mineral density
Study 37151894 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 37151894 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 37152602 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 37152926 — Surrogate Endpoint (SUR): Blood pressure
Study 37152926 — Surrogate Endpoint (SUR): Serum potassium
Study 37153087 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 37153587 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37153876 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 37153876 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 37155132 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 37155164 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 37155164 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 37156007 — Predictive Biomarker (PRD): ACVR1 mRNA
Genes: ACVR1; ACVRLK2
Study 37156249 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37156551 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 37156587 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 37156782 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 37158925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37158925 — Safety Biomarker (SAF): Reactive oxygen species
Study 37158938 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 37158938 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 37159034 — Surrogate Endpoint (SUR): Forced vital capacity
Study 37159195 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 37159195 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 37159251 — Surrogate Endpoint (SUR): Blood pressure
Study 37159264 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 37159276 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 37161377 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37161377 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 37161534 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 37161534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37161534 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37161678 — Surrogate Endpoint (SUR): Bone mineral density
Study 37161775 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37161796 — Surrogate Endpoint (SUR): Blood pressure
Study 37162700 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 37162923 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37163222 — Safety Biomarker (SAF): Interleukin 1
Study 37163349 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 37163360 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 37163621 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37163774 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37164012 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37164457 — Surrogate Endpoint (SUR): Blood pressure
Study 37164469 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 37164838 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 37164838 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37164837 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study 37165382 — Surrogate Endpoint (SUR): Blood pressure
Study 37165869 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 37165869 — Surrogate Endpoint (SUR): Blood pressure
Study 37165901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 37166257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37166484 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37166557 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study 37166557 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37166557 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 37166817 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37166817 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37166817 — Predictive Biomarker (PRD): Hormone receptor
Study 37166817 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 37166997 — Predictive Biomarker (PRD): SMAP mRNA
Genes: SMAP; C11orf58
Study 37167078 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study 37167764 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 37167764 — Predictive Biomarker (PRD): RELA mRNA
Genes: RELA; NFKB3
Study 37167996 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37168686 — Surrogate Endpoint (SUR): Blood pressure
Study 37169401 — Surrogate Endpoint (SUR): Blood pressure
Study 37169504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37169504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37169992 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 37170159 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 37170806 — Surrogate Endpoint (SUR): Blood pressure
Study 37170833 — Surrogate Endpoint (SUR): Blood pressure
Study 37171121 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 37171199 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 37171597 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37171597 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37171620 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37171634 — Predictive Biomarker (PRD): PPP1R13L mRNA
Genes: PPP1R13L; IASPP; NKIP1; PPP1R13BL; RAI
Study 37172100 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 37172100 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 37172116 — Surrogate Endpoint (SUR): Blood pressure
Study 37172200 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37172200 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 37172204 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37172783 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37172884 — Predictive Biomarker (PRD): CNGB3 mRNA
Genes: CNGB3
Study 37173099 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37173099 — Surrogate Endpoint (SUR): Blood pressure
Study 37173355 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37174730 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37174730 — Monitoring Biomarker (MOI): Procalcitonin
Study 37175874 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 37175874 — Safety Biomarker (SAF): miR-34c
Genes: MIR34C
Study 37175874 — Safety Biomarker (SAF): miR-22
Genes: MIR22
Study 37178647 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37178647 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37178647 — Predictive Biomarker (PRD): CLIP2 mRNA
Genes: CLIP2; CYLN2; KIAA0291; WBSCR3; WBSCR4; WSCR4
Study 37179415 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37179415 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37179415 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37179415 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 37179566 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 37179936 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 37180209 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 37180209 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 37180228 — Predictive Biomarker (PRD): DUOXA1 mRNA
Genes: DUOXA1; NIP; NUMBIP
Study 37180485 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37180499 — Surrogate Endpoint (SUR): Total kidney volume
Study 37180505 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 37180506 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 37180506 — Surrogate Endpoint (SUR): Blood pressure
Study 37181420 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 37182538 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37182538 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37182538 — Predictive Biomarker (PRD): Hormone receptor
Study 37182695 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 37183115 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37183520 — Predictive Biomarker (PRD): NOX1 mRNA
Genes: NOX1; MOX1; NOH1
Study 37183520 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 37183520 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 37183779 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 37183837 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 37183871 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 37185193 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 37185272 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 37185272 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 37185961 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37185961 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37186063 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 37186070 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37186094 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 37186094 — Surrogate Endpoint (SUR): Blood pressure
Study 37186772 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 37187198 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 37188177 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 37188782 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 37189057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37189151 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37189151 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37189151 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 37189151 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37190598 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 37190883 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37190970 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37191697 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 37191697 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 37191738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37192040 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 37192040 — Surrogate Endpoint (SUR): Complete renal response
Study 37192167 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 37192282 — Surrogate Endpoint (SUR): Blood pressure
Study 37192288 — Surrogate Endpoint (SUR): Blood pressure
Study 37192437 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37192642 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 37192729 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 37192729 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 37192741 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study 37192741 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): GZMB mRNA
Genes: GZMB; CGL1; CSPB; CTLA1; GRB
Study 37192741 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 37192741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37192754 — Surrogate Endpoint (SUR): Blood pressure
Study 37194008 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37194068 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 37194094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37194394 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 37194394 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 37194964 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37195023 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 37195023 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 37195023 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37195023 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 37195063 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37195370 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37195407 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 37195941 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37196061 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37196069 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37196396 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 37197845 — Surrogate Endpoint (SUR): Blood pressure
Study 37197845 — Surrogate Endpoint (SUR): Serum sodium
Study 37197909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37199745 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 37199789 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 37199789 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase